Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra versus standard of care in acute gout flares
2015-000696-27Phase 3Completed
- Sponsor
- prof. dr. M.A.F.J. van de Laar
- Start
- Jun 2015
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in gout comparing Anakinra with Standard of care (2 arms). Primary endpoint: Change in patient-reported pain in the index joint. Started Jun 2015; status: completed.
02
Drugs
anakinra
03
Conditions
gout
Beyond the preview
Go deeper on 2015-000696-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000696-27.